Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Learn more about the possibilities of this page

Enochian Biosciences Inc Stock

Price
Target price
€2.19

€2.19

-2.890%
-0.065
-2.890%
-
 
15.04.24 / Frankfurt WKN: A2PBYQ / Symbol: ENOB / Name: Enochian Biosciences / Stock / Small Cap /
Please give a prediction to see the opinions of the community
Buy
None
Sell
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Pros and Cons of Enochian Biosciences Inc in the next few years
Wizard

Enochian Biosciences Inc Stock

A loss of -2.890% shows a downward development for Enochian Biosciences Inc.
For the coming years our community has positive and negative things to say abot the Enochian Biosciences Inc stock. Criterium "Company culture" gathered the most positive votes but regarding "Innovation" there were negative voices in the community.
What does Enochian Biosciences do?

Pros and Cons of Enochian Biosciences Inc in the next few years

Pros
?
M***** P*******
?
C******** o* t** e**********
?
G***** c******* t* c**********
Cons
?
S********** s********
?
B****
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Your Opinion
Legal notice

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2023-11-11

Taking a tour through the financial landscape of Enochian Biosciences (ENOB), the first impression that strikes is one of a classic biotech start-up. The financial metrics weave a common story seen in this industry - expansive capitalization, significant investment in research and development, and as yet, a lack of tangible revenue. This isn't at all surprising given the unique nature of the biotech industry, where extensive time and monetary investment are prerequisites to achieving profitability.

Market Capitalization: With a market capitalization of around $195 million, Enochian Biosciences stands on a fair ground in the biotech start-up landscape. This capitalization reflects the value investors place on the company and its potential for future growth. Market capitalization also matters as it provides the company with the necessary financial impetus to invest in research and development or expansion.

Book Value: The book value per share of around 0.73 indicates the underlying value of the company's assets. This could provide a safety net for investors in the unlikely event of a company's dissolution, as the book value represents the amount investors would theoretically receive.

Show more
Register To Post